<?xml version="1.0" encoding="UTF-8"?>
<p>Rosemary’s beneficial properties are well known, such as analgesic, antinociceptive, antidepressant, anxiolytic, anti-inflammatory, antidiabetic, anti-neurodegenerative, and use to alleviate rheumatic pain, stomachache, and dysmenorrhea [
 <xref rid="B91-pharmaceutics-13-00631" ref-type="bibr">91</xref>]. Moreover, recently, the synergistic antinociceptive interaction of the ethanolic extract of rosemary officinalis and the 
 <italic>Syzygium aromaticum</italic> EO, suspended in 0.5% Tween 80–0.9% isotonic saline solutions, co-administered with ketorolac solution in rats, was demonstrated. Data were supported by a combination of conventional and alternative therapies [
 <xref rid="B92-pharmaceutics-13-00631" ref-type="bibr">92</xref>]. In other studies, it was indicated that extracts and purified components of carnosic acid and rosemary displayed significant growth inhibitory activity on a variety of cancers [
 <xref rid="B93-pharmaceutics-13-00631" ref-type="bibr">93</xref>]. The investigation confirmed the ability of rosemary/carnosic acid to inhibit the growth of human breast cancer cells and to synergize with curcumin, which inhibits the proliferation of ER-negative human breast cancer cells and induces G1 cell cycle arrest.
</p>
